The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia

Medical Microbiology and Immunology

Volumn 195, Issue 1, 2006, Pages 21-28

  Peppoloni, Samuele ^a,b   Colombari, Bruna ^a   Neglia, Rachele ^a   Quaglino, Daniela ^a   Iannelli, Francesco ^b   Oggioni, Marco Rinaldo ^b   Pozzi, Gianni ^b   Blasi, Elisabetta ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Killing; Microglial cells; PspC; Secretory activity; Streptococcus pneumoniae

Indexed keywords

BACTERIAL PROTEIN; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 2; MEMBRANE PROTEIN; MUTANT PROTEIN; NITRIC OXIDE; PROTEIN C; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL INTERACTION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FETAL BOVINE SERUM; HEAT; HUMAN; HUMAN CELL; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; SECRETION; SERUM; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ANIMALS; ANTIGENS, SURFACE; BACTERIAL PROTEINS; CELL LINE; CHEMOKINES; COLONY COUNT, MICROBIAL; GENE DELETION; INTERLEUKIN-10; MICE; MICROBIAL VIABILITY; MICROGLIA; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30544450863     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-005-0243-8     Document Type: Article

References (54)

1. Balachandran P, Brooks-Walter A, Virolainen-Julkunen A, Hollingshead SK, Briles DE (2002) Role of Pneumococcal surface protein C in nasopharingeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun 70:2526-2534
2. Blackmore TK, Fischetti VA, Sadlon TA, Ward HM, Gordon DL (1998) M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun 66:1427-1431
3. Barluzzi R, Brozzetti A, Mariucci G, Tantucci M, Neglia R, Bistoni F, Blasi E (2000) Establishment of protective immunity against cerebral cryptococcosis by means of a avirulent, non melanogenic Cryptococcus neoformans strain. J Neuroimmunol 109:75-86
4. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1999) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27:229-237
5. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749-795
6. Braun JS, Novak R, Murray PJ, Eischen CM, Susin SA, Kroemer G, Halle A, Weber JR, Tuomanen EI, Cleveland JL (2001) Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis 184:1300-1309
7. Briles DE, Hollingshead SK, Swiatlo E, Brooks-Walter A, Szalai A, Virolainen A, Mac Daniel LS, Benton KA, White P, Prellner K, Hermansson A, Aerts PC, Van Dijk H, Crain MJ (1997) PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist 3:401-408
8. Briles DE, Yother J, McDaniel LS (1988) Role of the pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev Infect Dis 10: S372-374
9. Brooks-Walter A, Briles DE, Hollingshead SK (1999) The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 67:6533-6542
10. Cheng Q, Finkel D, Hostetter M (2000) Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae. Biochemistry 39:5450-5457
11. Cundell DR, Gerard NP, Gerard C, Idänpaän-Heikkilä I, Tuomanen EI (1995) Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 377:435-438
12. Cundell DR, Weiser JN, Shen J, Joung A, Tuomanen EI (1995) Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun 63:757-761
13. Ding A H, Nathan C F, Stuehr D J (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 141:2407-2411
14. Fearon DT (1978) Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Nat Acad Sci USA 75:1971-1975
15. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22:219-240
16. Gray BM, Converse GM III, Dillon HCJr (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 142:923-933
17. Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS. (1997) SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol 25:1113-1124
18. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala U, Meri S (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276:8427-8435
19. Hostetter MK (1986) Serotypic variation among virulent pneumococci in deposition and degradation of covalently bound C3b. Implications for phagocytosis and antibody production. J Inf Dis 153:682-693
20. Iannelli F, Chiavolini D, Ricci S, Oggioni MR, Pozzi G (2004) Pneumococcal surface protein C contribules to sepsis caused by Streptococcus pneumoniae. Infect Immun 72(5):3077-3080
21. Idänpaän-Heikkilä I, Simon PM, Zopf D, Vullo T, Cahill P, Sokol K, Tuomanen EI (1997) Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis 176:704-712
22. Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L (2000) Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 275(47):37257-37263
23. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S (2002) Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol 168:1886-1894
24. Johnston RB Jr (1991) Pathogenesis of pneumococcal pneumonia. Rev Infect Dis 13:S509-517
25. Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA (2000) Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 182:840-847
26. Kotarsky H, Hellwage J, Johnsson E, Skerka C, Svensson HG, Lindahl G, Sjobring U, Zipfel PF (1998) Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol 160: 3349-3354
27. Luo R, Mann B, Lewis WS, Rowe A, Heath R, Stewart ML, Hamburger AE, Sivakolundu Siva, Lacy ER, Bjorkman PJ, Tuomanen E, Kriwacki RW (2005) Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. EMBO J 24:34-43
28. Meri S, Jarva H (2000) Complement regulatory proteins. In: Encyclopedia of the Life Sciences. Nature Publishing Group, London
29. Meri S, Pangburn MK (1990) Discrimination between activators and non activators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Nat Acad Sci USA 1987:3982-3986
30. Mitchell L, Smith SH, Braun JS, Herzog KH, Weber JR, Tuomanen EI (2004) Dual phases of apoptosis in pneumococcal meningitis. J Infect Dis 190:2039-2046
31. Morgan P, Gasque P (1996) Expression of complement in the brain: role in health and disease. Immunol Today 17(10):461-466
32. Mostov KE, Kaetzel CS (1999) Immunoglobulin transport and the polymeric immunoglobulin receptor. In: Lamm ME, Mestecky J, Lamm M, McGhee JR (eds) Mucosal immunology. Academic, New York
33. Mufson MA (1990) Streptococcus pneumoniae. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious diseases. Churchill Livingstone Inc., New York, pp 1539-1550
34. Musher DM (1992) Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin Infect Dis 14:801-807
35. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI (2004) Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190:1661-1669
36. Pangburn MK, Muller-Eberhard HJ (1978) Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc Nat Acad Sci USA 75:2416-2420
37. Paton JC (1998) Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol 6:85-87
38. Pearce BJ, Iannelli F, Pozzi G (2002) Construction of new unencapsulated (rough) strains of Streptococcus pneumoniae. Res Microbiol 1:2-10
39. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW (1999) Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30:77-105
40. Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, Pangburn MK, Rice PA (1998) A novel sialic acid binding site on factor H mediates serum resistance of syalited Neisseria gonorrhoeae. J Exp Med 187:743-752
41. Ring A, Weiser JN, Tuomanen EI (1998) Pneumococcal trafficking across the Blood-Brain-Barrier: molecular analysis of a novel biridectional pathway. J Clin Invest 102:347-360
42. Rosenow C, Ryan P, Weiser JN, Johnson S, Fontan P, Ortqvist A, Masure HR (1997) Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 25:819-829
43. Saleppico S, Boelaert JR, Sale FO, Mazzolla R, Morucci P, Bistoni F, Blasi E (1999) Differential effects of iron load on basal and interferon-gamma plus lipopolysaccharide enhance anticryptococcal activity by the murine microglial cell line BV-2. J Neuroimmunol 93:102-107
44. Sande MA, Tauber MG (2001) Pneumococcal meningitis: current pathophysiological concept. In: Tomasz (ed) Streptococcus pneumoniae: molecular biology and mechanisms of disease. Mary Ann Liebert Inc., Larchmont, pp 315-320
45. Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Lee C, Landaw I, Anguilar J, Hansen J (1999) Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatric Infect Dis J 18:757-763
46. Streit WJ, Walter SA, Pennel NA (2000) Reactive microgliosis. Prog Neurobiol 57:563-581
47. Tuomanen EI (1996) Molecular and cellular mechanisms of pneumococcal meningitis. Ann NY Acad Sci 797:42-52
48. Tuomanen EI, Masure HR (1997) Molecular and cellular biology of pneumococcal infection. Microb Drug Resist 3:297-308
49. van Furth AM, Roord JJ, van Furth R (1996) Roles of pro-inflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun 64:4883-4890
50. Weiser JN, Austrian R, Sreenivasan PK, Masure HR (1994) Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharygeal colonization. Infect Immun 62:2582-2589
51. Wourimaa T, Kayhty H (2002) Current state of pneumococcal vaccines. Scand J Immunol 56:111-129
52. Yother J, Briles DE. (1992) Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J Bacteriol 174:601-609
53. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M, Tuomanen EI (2000) The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102:827-837
54. Zweigner J, Jackowski S, Smith SH, van der Merwe M, Weber JR, Tuomanen EI (2004) Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain. J Exp Med 200:99-106